Brain Health Assessment for Dementia

Recruiting at 4 trial locations

Overseen By Alana Elop, MS

Age: 65+

Sex: Any

Trial Phase: Academic

Sponsor: Kaiser Permanente

Must not be taking: Dementia medications

Disqualifiers: Hospice care

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

3417 Participants Needed

Trial Summary

What is the purpose of this trial?

The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.

Research Team

Sascha Dublin, MD, PhD

Principal Investigator

KP Washington Health Research Institute

Deborah E Barnes, PhD, MPH

Principal Investigator

University of California, San Francisco

Eligibility Criteria

This trial is for individuals who are active patients at participating clinics, have not been diagnosed with dementia or Alzheimer's Disease, and aren't on medications for these conditions. They must also have enough data available to calculate what's called an eRADAR score. People currently in hospice care cannot participate.

Inclusion Criteria

I have never been diagnosed with dementia nor am I on dementia medication.

There is enough information to calculate the eRADAR score.

Active patient at participating clinic

Exclusion Criteria

I am currently in hospice care.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Brain Health Assessment

Eligible individuals are invited for a brain health assessment visit, and results are entered into the EHR

3 months

1 visit (in-person)

Follow-up

Participants are monitored for new dementia diagnoses and healthcare utilization

12 months

Extended Follow-up

Continued monitoring of healthcare utilization and dementia diagnoses

18 months

Treatment Details

Interventions

• Brain Health Assessment

Trial Overview The study is testing a new strategy to detect dementia early in primary care settings by using a Brain Health Assessment tool. It aims to be low-cost and patient-friendly while improving the identification of cognitive issues.

Participant Groups

Group I: Brain Health Intervention Experimental Treatment 1 Intervention

* Calculate eRADAR scores using EHR data to identify eligible individuals * Invite eligible individuals for brain health assessment visit * Enter results of brain health assessment visit into EHR * Provide summary of results and recommended next steps to the Primary Care Physician and participant

Group II: Usual care Active Control 1 Intervention

Individuals who meet eligibility criteria will receive usual care.

Who Is Running the Clinical Trial?

Kaiser Permanente

Lead Sponsor

Trials

563

Recruited

27,400,000+

University of California, San Francisco

Collaborator

Trials

2,636

Recruited

19,080,000+